NCT00370149

Brief Summary

The primary purpose of the study is to determine if a therapeutic difference exists between central venous catheters impregnated with minocycline and rifampin and conventional catheters not impregnated with antibiotics when used in children at high risk for bloodstream infections (CABSI) after cardiac surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
326

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Sep 2006

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 30, 2006

Completed
2 days until next milestone

Study Start

First participant enrolled

September 1, 2006

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
5.8 years until next milestone

Results Posted

Study results publicly available

February 24, 2016

Completed
Last Updated

February 24, 2016

Status Verified

January 1, 2016

Enrollment Period

3.7 years

First QC Date

August 28, 2006

Results QC Date

October 19, 2015

Last Update Submit

January 27, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Catheter-related Bloodstream Infections (CRBSI) Per 1000 Catheter Days

    Rates of CRBSI defined as 1. micro-organism isolated from a blood culture; 2. Clinical manifestations of infection such as fever (≥38 C) and/or hypotension (defined according to age-related practice guidelines for systolic blood pressure); 3. No apparent source for the bloodstream infection except for the catheter.

    Participants were followed for the duration of the hospital stay, an average of 6 days.

Secondary Outcomes (2)

  • Episodes of Clinical Sepsis and/or Infection With Identified Source Other Than Catheter

    Participants were followed for the duration of hospital stay, an average of 6 days.

  • Death

    Participants were followed for the duration of the hospital stay, an average of 6 days.

Study Arms (2)

Antibiotic-impregnated Catheters (M/R)

ACTIVE COMPARATOR

Interventions is insertion intra-operatively of catheters impregnated with minocycline and rifampin to determine if their is a therapeutic difference between this catheter and the placebo (non-impregnated) catheter. The catheters are sized to accommodate children in different size ranges: Cook Inc. Double Lumen 4 Fr., 8 cm long, (C-UDLM-401J-ABRM-HC), 5 Fr., 8 cm long, (C-UDLM-501J-ABRM-HC), and 5 Fr., 12 cm long, (C-UDLMY-501J-RSC-ABRM-HC).

Device: Antibiotic-impregnated Catheters (M/R)

Non-impregnated Catheter (C/S)

PLACEBO COMPARATOR

Intervention is insertion intra-operatively of conventional, non-impregnated catheters. There are two sizes to accommodate children in different size ranges: Cook Incorporated Double Lumen Polyurethane Central Venous Catheters, 4 Fr., 8 cm long, (C-UDLM-401J), 5 Fr., 8 cm long, (C-UDLM-501J), and 5 Fr., 12 cm long (C-UDLM-501J-RSC).

Device: Non-impregnated Catheters (C/S)

Interventions

Patients randomized to this arm will have the antibiotic-impregnated catheters inserted intra-operatively. The catheters are sized to accommodate children in different size ranges.

Antibiotic-impregnated Catheters (M/R)

Patients randomized to this arm will have the central venous catheter inserted intra-operatively. The catheters are sized to accommodate children in different size ranges.

Non-impregnated Catheter (C/S)

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age \< 18 years
  • Cardiovascular surgery patient with a case complexity warranting CVC placement longer than 3 days
  • Study devices of appropriate size for patient use without modification
  • Informed consent obtained prior to patient entering the operating room

You may not qualify if:

  • Age ≥ 18 years
  • Drug allergy to minocycline, other tetracyclines, or rifampin
  • Ventricular assist device (VAD) therapy
  • Extracorporeal membrane oxygenation (ECMO) therapy
  • Patients undergoing cardiac transplant
  • Any active infection or being treated for bacteremia at the time of randomization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riley Hospital for Children

Indianapolis, Indiana, 46202, United States

Location

Related Publications (1)

  • Cox EG, Knoderer CA, Jennings A, Brown JW, Rodefeld MD, Walker SG, Turrentine MW. A Randomized, Controlled Trial of Catheter-Related Infectious Event Rates Using Antibiotic-Impregnated Catheters Versus Conventional Catheters in Pediatric Cardiovascular Surgery Patients. J Pediatric Infect Dis Soc. 2013 Mar;2(1):67-70. doi: 10.1093/jpids/pis066. Epub 2012 Jul 4.

Limitations and Caveats

A blinded interim analysis by an independent Data Safety Monitoring Board resulted in early termination of the study: of 288 evaluable patients, the rates of CRBSI and line-related complications were similar between the 2 groups.

Results Point of Contact

Title
Elaine G Cox, MD
Organization
Riley Hospital for Children

Study Officials

  • Elaine G. Cox, MD

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2006

First Posted

August 30, 2006

Study Start

September 1, 2006

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

February 24, 2016

Results First Posted

February 24, 2016

Record last verified: 2016-01

Data Sharing

IPD Sharing
Will not share

Locations